Harmonic Discovery Launches With $8M
Summary
NEW YORK, NY, Harmonic Discovery announces its launch today with $8 million in seed funding. Harmonic Discovery, a therapeutics company building an integrated computational and experimental platform for kinase drug discovery and targeted polypharmacology, announces its launch today with $8 million in seed funding. The round was led by Innovation Endeavors with participation from Fifty Years, Y Combinator, Boom Capital, Caffeinated Capital and select angel investors. Dr. Joel Dudley, PhD, Partner at Innovation Endeavors, joins as a new Board Member. Founded in 2021 and headquartered in New York City, Harmonic Discovery is a therapeutics company building an integrated computational and experimental platform for kinase drug discovery and targeted polypharmacology.
Classifications
AskAI Classifications
LabelsLinked Companies
